tiprankstipranks
Trending News
More News >
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
Advertisement

Jasper Therapeutics (JSPR) Income Statement

Compare
1,033 Followers

Jasper Therapeutics Income Statement

Last quarter (Q3 2025), Jasper Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Jasper Therapeutics's net income was $-18.74M. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 76.24M$ 68.86M$ 51.20M$ 36.83M$ 20.68M
Depreciation and Amortization
$ 1.37M$ 1.11M$ 975.00K$ 377.00K$ 20.68M
EBITDA
$ -74.87M$ -67.75M$ -50.22M$ -36.46M$ 0.00
Operating Income
$ -76.24M$ -68.86M$ -51.20M$ -36.83M$ -20.68M
Other Income/Expenses
$ 4.97M$ 4.40M$ 13.51M$ 6.20M$ -10.99M
Pretax Income
$ -71.27M$ -64.47M$ -37.69M$ -30.64M$ -31.67M
Net Income
$ -71.27M$ -64.47M$ -37.69M$ -30.64M$ -31.67M
Per Share Metrics
Basic EPS
$ -4.89$ -6.18$ -10.33$ -26.89$ -183.08
Diluted EPS
$ -4.89$ -6.18$ -10.33$ -26.89$ -183.08
Weighted Average Shares Outstanding
14.58M 10.44M 3.65M 1.14M 172.00K
Weighted Average Shares Outstanding (Diluted)
14.58M 10.44M 3.65M 1.14M 172.98K
Currency in USD

Jasper Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis